Status: Recruiting
Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
The goal of this trial is to test the efficacy and safety of cardenilimab combined with chemotherapy in the conversion therapy of locally advanced unresectable esophageal squamous cell carcinoma. type of study: clinical trial
Participants needed: 43
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Li ZhangUpdated: Jun 26, 2025Locations: 1
Eligibility criteria
Absolute neutrophil count (ANC) ≥1.5x109/L without using granulocyte colony-stim... [+8]
Other malignant diseases diagnosed within 5 years before the first dose (excludi... [+13]